The grade of gliomas (P = 0.034, HR 1.737, 95%CI 1.0–2.93) and MGMT expression in immunohistochemistry (P = 0.007, HR 2.211, 95%CI 1.2–3.9) were the independent prognostic factors of PFS. This evidence concerns the gene MGMT and central nervous system cancer.